Finding Cures Starts Here


The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma.  LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.

null

Scientific Advisory Board

The LRF Scientific Advisory Board (SAB) is comprised of 45 world-renowned lymphoma experts, who seek out the most innovative and promising lymphoma research projects to support.

null

Research Grant Programs

LRF remains dedicated to finding cures for lymphoma through an aggressively-funded program for researchers.

null

Lymphoma Consortia, Initiatives & Scientific Workshops

LRF global lymphoma consortia, research initiatives, and scientific workshops help to mobilize the research community, overcome systemic challenges and speed the progress by which new treatments are developed.

Investing in the Best and Brightest Researchers, Achieving Breakthroughs

LRF funds the very best science that has the greatest potential to impact patients and ensures the best and brightest researchers remain in the field.
To date, LRF has funded nearly $65 million in lymphoma-specific research and has supported key breakthroughs including:

  • First In-Human Clinical Trial of Adoptive Immunotherapy in Follicular Lymphoma

  • First Publication of the Whole-Genome Sequencing of Mantle Cell Lymphoma

  • Identifying the Role RNA Splicing Plays in Chronic Lymphocytic Leukemia

  • Using Micro RNA Array to Identify Biomarkers that Play a Critical Role in Mantle Cell Lymphoma Drug Resistance and Progression

  • Identifying the Mechanism Behind Ibrutinib Resistance in Mantle Cell Lymphoma

“LRF had a profound impact at the beginning of my academic career, when I needed the support most. I will always be grateful to LRF for its continuous investment in supporting innovative science, clinical research and educational programs.” – Dr. Eduardo Sotomayor, LRF Scientific Advisory Board Member

Meet Our 2021 Researchers

David A. Bond, MD
The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital
LRF Scholar

P. Connor Johnson, MD
Massachusetts General Hospital
LRF Scholar

Niloufer Khan, MD, MS
Memorial Sloan Kettering Cancer Center
LRF Scholar

Arushi Khurana, M.B.B.S
Mayo Clinic, Rochester, MN
LRF Scholar

Luis Malpica Castillo, MD
The University of Texas M.D. Anderson Cancer Center
LRF Scholar

Erin Mulvey, MD
Weill Cornell Medical College
LRF Scholar

Jason Romancik, MD
Emory University – Winship Cancer Institute
LRF  Scholar

Suchitra Sundaram, MD
Roswell Park Cancer Institute
LRF Scholar

Tomohiro Aoki, PhD
British Columbia Cancer Research Center
LRF Scholar

Zachary Epstein-Peterson, MD
Memorial Sloan Kettering Cancer Center
LRF Scholar

Rossella Marullo, MD, PhD
Weill Cornell Medicine
LRF Scholar

Coraline Mlynarczyk, PhD
Weill Cornell Medicine College
LRF Scholar

Patrizia Mondello, MD, PhD
Mayo Clinic, Rochester
LRF Scholar

Brian Sworder, MD, PhD
Stanford University School of Medicine
LRF Scholar

FINDING CURES STARTS HERE
25 Years of Innovation & Progress

1995 was a significant year for the Lymphoma Research Foundation (LRF)—it was then that LRF realized its dual mission to eradicate lymphoma and to serve those touched by this disease.

Finding cures starts here.  Through lymphoma-specific research grants and consortia, LRF-supported researchers have been involved in many of the most significant lymphoma breakthroughs witnessed in the past quarter-century.

RESEARCH NEWS | View all >